57 related articles for article (PubMed ID: 7716673)
1. [Characteristics of patients with low grade malignant lymphoma and long survival].
Martínez-Francés A; Lopez-Guillermo A; Esteve J; Bosch F; Terol MJ; Montserrat E; Rozman C
Sangre (Barc); 1995 Feb; 40(1):53-7. PubMed ID: 7716673
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
[TBL] [Abstract][Full Text] [Related]
3. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
van Besien KW; Mehra RC; Giralt SA; Kantarjian HM; Pugh WC; Khouri IF; Moon Y; Williams P; Andersson BS; Przepiorka D; McCarthy PL; Gajewski JL; Deisseroth AB; Cabanillas FF; Champlin R
Am J Med; 1996 Mar; 100(3):299-307. PubMed ID: 8629675
[TBL] [Abstract][Full Text] [Related]
5. [Post-therapeutic evolution and prognostic factors of intestinal lymphomas, Retrospective analysis of 42 cases].
Sánchez-Fayos MP; Hernández Guío C; Rivas MC; Outeiriño J; González-Campos C; Lobo F
Sangre (Barc); 1993 Dec; 38(6):455-62. PubMed ID: 8171381
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
[TBL] [Abstract][Full Text] [Related]
7. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
Wong WW; Schild SE; Halyard MY; Schomberg PJ
J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
[TBL] [Abstract][Full Text] [Related]
8. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
9. Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors.
Bremnes RM; Vik A; Helbekkmo N
Anticancer Res; 1998; 18(3B):1921-9. PubMed ID: 9677445
[TBL] [Abstract][Full Text] [Related]
10. [Long-term survival in chronic myeloid leukemia: frequency and fundamental characteristics in a series of 100 patients].
Cervantes F; Bosch F; Terol MJ; Pereira A; Rozman C
Sangre (Barc); 1993 Apr; 38(2):93-6. PubMed ID: 8516734
[TBL] [Abstract][Full Text] [Related]
11. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
van Besien K; Rodriguez A; Tomany S; Younes A; Donato M; Sarris A; Giralt S; Mehra R; Andersson B; Gajewski J; Champlin R; Cabanillas F
Bone Marrow Transplant; 2001 Feb; 27(4):397-404. PubMed ID: 11313669
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in low-grade lymphoma].
Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
18. [Aplastic anemia--clinical characteristics and survival analysis].
Milosević R; Antonijević N; Janković G; Babić D; Colović M
Srp Arh Celok Lek; 1998; 126(7-8):234-8. PubMed ID: 9863388
[TBL] [Abstract][Full Text] [Related]
19. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
Barbieri E; Cammelli S; Mauro F; Perini F; Cazzola A; Neri S; Bunkheila F; Ferrari S; Brandoli V; Zinzani P; Mercuri M; Bacci G
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):760-4. PubMed ID: 15183479
[TBL] [Abstract][Full Text] [Related]
20. To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center.
Zinzani PL; Magagnoli M; Gherlinzoni F; Bendandi M; Albertini P; Merla E; Tura S
Haematologica; 1998 Jun; 83(6):502-7. PubMed ID: 9676022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
